A System to Select for Mutant LLC-PK₁ Cells Affected in camp Mediated Hormonal Response Using a Photoactivatable Analogue of Vasopressin

References

• Gilman A. G., Sternweis P. C., Howlett A. C., Ross E. M. Biochemical and genetic resolution of components of the S49 lymphoma adenylase cyclase system. Hormones and cell culture, part A, G. H. Sato, R. Ross. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1979; 299–315
   Google Scholar
• Gilman A. G. G-proteins and dual control of adenylate cyclase. Cell 1984; 36: 577–579
   PubMed Web of Science ®Google Scholar
• Steinberg R. A. Molecular approaches to the study of cyclic AMP action 1983 in Biochemical actions of hormones, G. Litwack. Academic Press, New York, Vol. 11: 25–65
   Google Scholar
• Lohmann S. M., Walter U. Regulation of the cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinase. Adv.Cyclic Nucleotide Protein Phosphorylation Res. 1984; 18: 63–117
   PubMedGoogle Scholar
• Hemmings B. A. Regulation of cAMP-dependent protein kinase in cultured cells. Curr. Topics Cell Regulation 1985; 27: 117–132
   Google Scholar
• Hull R. N., Cherry W. R., Weaver G. W. The origin and characteristics of a pig kidney cell strain. LLC-PK₁ In vitro 1976; 12: 670–677
   PubMedGoogle Scholar
• Dayer J. M., Vassalli J. D., Bobbit J. L., Hull R. N., Reich E., Krane S. M. Calcitonin stimulates plasminogen activator in porcine renal tubular cells: LLC-PK1. J.Cell Biol. 1981; 91: 195–200
   Google Scholar
• Jans D. A., Resink T. J., Wilson E. R., Reich E., Hemmings B. A. Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness: a pleiotropic lesion in receptor function. Eur.J.Biochem. 1986; 160: 407–412
   Google Scholar
• Jans D. A., Resink T. J., Hemmings B. A. Complementation between LLC-PK1 mutants affected in polypeptide hormone receptor function. Eur.J.Biochem. 1987; 162: 571–576
   Google Scholar
• Nagamine Y., Sudol M., Reich E. Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell 1983; 32: 1181–1190
   PubMed Web of Science ®Google Scholar
• Jans D. A., Hemmings B. A. LLC-PK1 cell mutants in cAMP metabolism respond normally to phorbol esters. FEBS Lett. 1986; 205: 127–131
   Google Scholar
• Jans D. A., Hemmings B. A. cAMP metabolism in the porcine kidney epithelial cell line LLC-PK1: the central role of the cAMP dependent protein kinase in CAMP mediated gene induction. Adv. in Second Messenger and Phosphoprotein Res. 1988; 21: 109–121
   Google Scholar
• Fahrenholz F., Boer R., Crause P., Toth M. V. Photoaffinity labelling of the renal V2 vasopressin receptor -identification and enrichment of a vasopressin-binding subunit. Eur.J.Biochem. 1985; 152: 589–595
   PubMedGoogle Scholar
• Fahrenholz F., Eggena P., Gazis D., Toth M. V., Schwartz I. L. Photoreactive neurohypophyseal hormone analogs: effects on transport processes in mammalian and amphibian epithelia. Endocrinology 1986; 118: 1026–1031
   Google Scholar
• Eggena P., Fahrenholz F., Schwartz I. A. Irreversible stimulation of hydroosmotic response in toad bladder by photoaffinity labelling with Phe2 Phe(p-N3)3 vasopressin. Endocrinology 1983; 113: 1413–1421
   Google Scholar
• Eggena P., Fahrenholz F., Schwartz I. A. Covalent linkage of Phe2 Phe(p-N3)3 AVP to vasopressin receptors in toad bladder during photolysis. Am.J.Physiol. 1984; 246: C486–C493
   Google Scholar
• Jans D. A., Gajdas E. L., Dierks-Ventling C., Hemmings B. A., Fahrenholz F. Long term stimulation of cAMP production in LLC-PK1 pig kidney cells by salmon calcitonin or a photoacti-vatable analogue of vasopressin. Biochim. Biophys.Acta 1987; 930: 392–400
   Google Scholar
• Finlay G. J., Baguley B. C., Wilson W. R. A semi automated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal.Biochem. 1984; 139: 272–277
   PubMed Web of Science ®Google Scholar
• Jans D. A., Resink T. J., Hemmings B. A. The dependence of urokinase-type plasminogen activator induction on cAMP-dependent protein kinase activation in LLC-PK1 cells. Biochem.J. 1987; 243: 413–418
   Google Scholar
• Devis P. E., Grohol S. H., Taub M. Dibutyryl cyclic AMP resistant MDCK cells in serum-free medium have reduced cyclic AMP dependent protein kinase activity and a diminished effect of PGE1 on differentiated function. J.Cell. Physiol. 1985; 125: 23–25
   Google Scholar
• Lamp S. J., Findlay D. M., Moseley J. M., Martin T. J. Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T47D). J.Biol.Chem. 1981; 256: 12269–12274
   PubMed Web of Science ®Google Scholar
• Bradford W. M. A rapid, sensitive method for the question of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–249
   PubMed Web of Science ®Google Scholar
• Fahrenholz F., Boer R., Crause P., Fritzsch G., Grzonka Z. Interactions of vasopressin agonists and antagonists with membrane receptors. Eur.J.Pharmacol. 1984; 100: 47–58
   PubMed Web of Science ®Google Scholar
• Steinberg R. A., Steinberg M. G., Van Daalen Wetters T. A variant of S49 mouse lymphoma cells with enhanced secretion of cyclic AMP. J.Cell.Physiol. 1979; 100: 579–588
   PubMedGoogle Scholar
• Frimmer M., Ziegler K. Photoaffinity labeling of whole cells by flashed light: a simple apparatus for high energy ultraviolet flashes. Biochim.Biophys.Acta 1986; 855: 143–146
   Google Scholar
• Fahrenholz F., Hackenberg M., Müller M. Identification of a myometrial oxytocin-receptor protein. Eur.J.Biochem. 1988; 174: 81–85
   Google Scholar
• Sibley D. R., Lefkowitz R. J. Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 1987; 317: 124–129
   Google Scholar
• Benovic J. L., Bouvier M., Caron M. G., Lefkowitz R. J. Regulation of adenyl cyclase-coupled β-adrenergic receptors. Ann.Rev.Cell Biol. 1988; 4: 405–428
   PubMedGoogle Scholar